Singulair, Montelukast News

There are so many medications out there. We'll tell you what you need to know. Black box warnings are a type of labeling that the Federal Drug Administration requires pharmaceutical companies to use when a drug has possible side effects that are dangerous, rather than just annoying.

OTTAWA a ' The side-effects of a popular asthma medication that has been sold in Canada for 12 years has been linked to suicide attempts and thoughts of suicide, as well as feelings of depression and hostility.

Singulair is one of the most popular allergy and asthma medications on the market, but the Food and Drug Administration is investigating reports of serious behavioral side effects in children.

Oral medications for allergic rhinitis include antihistamines and decongestants.

Lynne Faraone created this wall of inspiration in her Mentor home. She says hope especially helped her as she fought for a warning label on the asthma and allergy medication Singulair.

Changes are on the way for a popular asthma and allergy medication. The Food and Drug Administration wants the makers of Singulair and other leukotrienes to include precautionary labeling about behavioral symptoms and mood changes.

WARSAW, POLAND, June 22, 2009 /24-7PressRelease/ -- Last week the FDA knocked the wind out of asthmatics by requesting the manufacturers of Singulair, a popular leukotriene blocking asthma and allergy drug, to upgrade their warning against psychotic side effects.

This roundup includes the following brief clinical practice updates: The FDA is warning consumers to stop using three Zicam intranasal products.

REPORT OF A CASE A 36-year-old woman presented with a painful and pruritic eruption on both feet.

The FDA has requested that warnings of mood changes and suicidal behavior be placed on the label of Singulair, which is also facing challenges over the validity of its patent.

Merck 's handling of the FDA's order that it update warnings on its Singulair asthma drug has been less than perfect, according to commenters on CafePharma.com. The FDA has required Merck, among other asthma drugmakers, to add a message warning of suicidal thoughts on its labels.

The FDA's new requirement for tighter warnings on a range of asthma drugs will not come as a surprise to Dr.

The U.S. Food and Drug Administration provided further updated safety information on a class of asthma drugs known as leukotriene modifiers.

Merck & Company 's top-selling drug, the asthma medication Singulair, and similar medicines should come with a caution about reports of psychiatric problems in some patients, the Food and Drug Administration said.

The U.S. Food and Drug Administration on Friday requested that the makers of a class of asthma drugs called leukotriene receptor agonists place a "precaution" on the drugs' labeling, warning of the potential for neuropsychiatric events.

Jun 12, 2009 - Merck & Co., Inc. issued the following statement in response to today's communication from the U.S. Food & Drug Administration addressing updated information on leukotriene inhibitors, including SINGULAIR .

WASHINGTON a ' New labels on popular asthma drugs such as Merck's Singulair must highlight language about suicidal behavior, depression and anxiety seen in a small number of patients, federal regulators said Friday.

Leukotriene Inhibitors: Montelukast , Zafirlukast , and Zileuton June 12, 2009 Audience: Pulmonology healthcare professionals FDA provided healthcare professionals with updated information on the original March 2008 early communication and January 2009 follow-up communication about the ongoing safety review for the leukotriene inhibitors, ...

The FDA has provided further updated safety information on a class of asthma drugs known as leukotriene modifiers.

Adults, not just kids, can develop asthma. Well, the warm weather has finally arrived, and so has the urge to spend as much time outdoors as possible.